Sienna Looks For ‘Strategic Alternatives’

Westlake Village biotech faces capital shortage for research.

By AMY STULICK Staff Reporter
HEALTH CARE & BIOTECH

Sienna Biopharmaceuticals has retained Cowen as an independent financial advisor to explore “financial and strategic alternatives” to boost shareholder value, the company said in a statement. The Westlake Village research biotech will continue to...

Read latest Inside The Valley online.

Online newspapers at PressDisplay.